|
Volumn 14, Issue 3, 1988, Pages 417-424
|
Retrospective analysis of stage I and II indolent lymphomas at the National Cancer Institute
a a a a a a a |
Author keywords
Chemotherapy; Early stage malignant lymphoma; Prognostic factors; Radiotherapy
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
CYCLOPHOSPHAMIDE;
CYTARABINE;
METHOTREXATE;
PREDNISONE;
VINCRISTINE;
ADOLESCENT;
ADULT;
AGED;
CANCER CHEMOTHERAPY;
FEMALE;
HISTOLOGY;
HUMAN;
LYMPHOMA;
MAJOR CLINICAL STUDY;
MALE;
METHODOLOGY;
PRIORITY JOURNAL;
PROGNOSIS;
RADIOTHERAPY;
ADOLESCENT;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BLEOMYCIN;
COMBINED MODALITY THERAPY;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DOXORUBICIN;
ETOPOSIDE;
FEMALE;
HUMAN;
LYMPHOMA, NON-HODGKIN;
MALE;
METHOTREXATE;
MIDDLE AGE;
PREDNISONE;
PROCARBAZINE;
PROGNOSIS;
RADIOTHERAPY, HIGH-ENERGY;
RETROSPECTIVE STUDIES;
VINCRISTINE;
|
EID: 0024156917
PISSN: 03603016
EISSN: None
Source Type: Journal
DOI: 10.1016/0360-3016(88)90254-4 Document Type: Article |
Times cited : (75)
|
References (22)
|